Phase IISmall Molecule
Compound 61399
Formula Pending
Molecular Mass
N/A
CAS Registry
AUTO-061399
Risk Class
MODERATE
Last Audit
Jan 20, 2108
Research Abstract
Small Molecule candidate engineered for cellular repair initiatives with automated dossier coverage.
Compound 61399 is a small molecule asset inside small molecule innovation track initiatives, optimized for cellular repair and tissue regeneration.
The dossier currently sits in phase ii with a moderate risk rating, meaning it is requires layered oversight with metabolic labs.
Supply records cite CAS AUTO-061399 with updates logged 2108-01-20.
Acquisition Protocol
Authorized research personnel may request deployment of this compound for laboratory analysis.
Primary Vectors
Cellular repairTissue regeneration
Nomenclature
CX-61399Small Molecule Program 61399
Reference Material
- [1] Anubis Compound Registry • CAS AUTO-061399
- [2] Operations Pulse • Small Molecule innovation track
- [3] Risk Governance Ledger • MODERATE clearance for COMPOUND-61399